Sherwin-Williams (NYSE:SHW) Stock Rating Upgraded by Barclays

Sherwin-Williams (NYSE:SHW) was upgraded by equities research analysts at Barclays to a “hold” rating in a research note issued on Monday, Zacks reports.

Several other equities research analysts also recently commented on SHW. Berenberg Bank upped their price target on shares of Sherwin-Williams from $380.00 to $400.00 and gave the company a “buy” rating in a research report on Wednesday, July 29th. Weiss Ratings raised shares of Sherwin-Williams from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, October 9th. Jefferies Financial Group reiterated a “hold” rating and set a $375.00 price objective (up from $360.00) on shares of Sherwin-Williams in a research report on Tuesday, July 28th. BMO Capital Markets reiterated an “outperform” rating on shares of Sherwin-Williams in a research report on Monday, September 28th. Finally, BNP Paribas Exane boosted their target price on shares of Sherwin-Williams from $345.00 to $360.00 and gave the company a “neutral” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $382.08.

Sherwin-Williams Price Performance

NYSE SHW opened at $324.21 on Monday. The stock’s 50-day moving average price is $334.68 and its two-hundred day moving average price is $328.14. The company has a current ratio of 0.73, a quick ratio of 0.46 and a debt-to-equity ratio of 2.16. The company has a market cap of $78.71 billion, a PE ratio of 29.88, a PEG ratio of 2.41 and a beta of 1.08. Sherwin-Williams has a 1 year low of $289.86 and a 1 year high of $377.77.

Sherwin-Williams (NYSE:SHW) last posted its quarterly earnings data on Tuesday, July 28th. The specialty chemicals company reported $3.70 EPS for the quarter, beating analysts’ consensus estimates of $3.52 by $0.18. Sherwin-Williams had a net margin of 11.01% and a return on equity of 67.97%. The company had revenue of $6.79 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same period in the prior year, the firm earned $3.38 earnings per share. The business’s quarterly revenue was up 7.5% on a year-over-year basis. Sherwin-Williams has set its FY 2026 guidance at 11.800-12.200 EPS. On average, analysts predict that Sherwin-Williams will post 12.09 EPS for the current year.

Insider Activity

In other news, insider Justin Binns sold 13,500 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $352.70, for a total value of $4,761,450.00. Following the transaction, the insider owned 21,937 shares in the company, valued at $7,737,179.90. This represents a 38.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Karl J. Jorgenrud sold 7,886 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the completion of the sale, the insider directly owned 11,944 shares of the company’s stock, valued at $4,398,975.20. This trade represents a 39.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new stake in shares of Sherwin-Williams in the second quarter worth about $6,100,083,000. Wellington Management Group LLP boosted its stake in shares of Sherwin-Williams by 133.7% during the 2nd quarter. Wellington Management Group LLP now owns 2,784,679 shares of the specialty chemicals company’s stock worth $958,821,000 after acquiring an additional 1,593,009 shares in the last quarter. Amundi increased its holdings in shares of Sherwin-Williams by 20.6% during the 1st quarter. Amundi now owns 2,200,895 shares of the specialty chemicals company’s stock valued at $705,497,000 after acquiring an additional 376,505 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in shares of Sherwin-Williams during the 2nd quarter valued at about $547,097,000. Finally, Dimensional Fund Advisors LP raised its stake in shares of Sherwin-Williams by 2.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,417,166 shares of the specialty chemicals company’s stock valued at $454,226,000 after acquiring an additional 39,853 shares in the last quarter. 77.67% of the stock is owned by hedge funds and other institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company (NYSE: SHW) manufactures, distributes and sells paints, coatings, floorcoverings and related products. Its offerings serve residential, commercial, industrial, automotive and specialty applications, including architectural paints, protective and marine coatings, industrial finishes, automotive refinishing products, wood stains and surface-preparation materials.

Founded in 1866 by Henry Sherwin and Edward Williams, the company is headquartered in Cleveland, Ohio.